Bristol Myers Squibb Canada
15 meetings with public office holders, Mar 13, 2026 to Jul 29, 2026.
Meetings over time
- Mar 2026: 2 meetings, with Justine Frame, Nasser Haidar, Galen Richardson
- Apr 2026: 3 meetings, with Sony Perron, Ritu Banerjee, Jocelyne Voisin, Shalene Curtis-Micallef, Daniel MacDonald
- May 2026: 2 meetings, with Jocelyne Voisin, Shalene Curtis-Micallef, Linsey Hollett, Sandenga Yeba, Justine Frame
- Jun 2026: 6 meetings, with Marie-Pier Fontaine, Kathleen McLellan, Jade Mallette, Justine Frame, Ritu Banerjee
- Jul 2026: 2 meetings, with Abla Hanna, Isabelle Mondou, Greg Reade, Justine Frame
Mar 2026peak 6 in a monthJul 2026
Hover or focus a month to see who was met.
What they lobby about
- Economic Development15
- Federal-Provincial Relations15
- Health15
- International Trade15
- Research and Development15
- Science and Technology15
- International Relations7
- Natural Resources2
The registry's own subject categories, chosen by the lobbyist on each filing. Each one opens its own page.
Who they met
Liberal2 met · 2 meetings
Not in Arena's member list31 met · 78 meetings
- Justine Frame
- Ritu Banerjee
- Jocelyne Voisin
- Sandenga Yeba
- Shalene Curtis-Micallef
- Pamela Aung-Thin
- Elizabeth Wong
- Manuela Tomic
- Linsey Hollett
- Mackenzy Metcalfe
- Nasser Haidar
- Kaili Levesque
- Sony Perron
- Abla Hanna
- Annahat Kochar
- Annahat Koshar
- Brent Lawlor
- Celia Lourenco
- Daniel MacDonald
- Fatoumata Bah
- Galen Richardson
- Greg Reade
- Isabelle Mondou
- Jade Mallette
- Jibril Hussein
- Kaili Levesque
- Kathleen McLellan
- Marie-Pier Fontaine
- Sara O'Connor
- Scott Lohnes
- Supriya Sharma
Health Canada (HC) (42) · Innovation, Science and Economic Development Canada (ISED) (16) · Treasury Board Of Canada Secretariat (TBS) (6) · Privy Council Office (PCO) (5) · Finance Canada (FIN) (3) · Intergovernmental Affairs Secretariat (IGA) (3)
In their own words
- Bill C-64 (Pharmacare Act - 2024) Patented Medicine Prices Review Board (PMPRB) Reform Most Favored Nation National Pharmacare Drugs for Rare Diseases
Meetings from the Commissioner of Lobbying of Canada. Canada does not require lobbyists to disclose what they spend, so there is no lobbying budget to report here — only the meetings they filed.